Day

May 2, 2022

2
May
2022

Biopharmas: Digitizing, But Not Quite Digital

What a difference two years makes. In January 2020, I left my role as a senior partner at a corporate life-science venture fund to pursue my interest in what I recognized as a captivating frontier: the intersection of biopharma with emerging digital and data technology. I set up an independent consultancy, and advised senior R&D executives in both large and...
Read More